American Journal of Cardiology
Volume 104, Issue 2 , Pages 164-168 , 15 July 2009

Clinical Significance of Borderline Elevated Troponin I Levels Across Different Assays in Patients With Suspected Acute Coronary Syndrome

  • Maliha Zahid, MD

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • Corresponding Author InformationCorresponding author: Tel: 412-648-9269; fax: 412-624-1401
    • ,
  • Chester B. Good, MD, MPh

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
    • Center for Healthy Equity and Research Promotion, Pittsburgh, Pennsylvania
    • ,
  • Ish Singla, MD

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Ali F. Sonel, MD

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania
    • Center for Healthy Equity and Research Promotion, Pittsburgh, Pennsylvania

Received 13 February 2009 ,Revised 10 March 2009 ,Accepted 10 March 2009.

References 

  1. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (Universal definition of myocardial infarction). J Am Coll Cardiol. 2007;50:2173–2195
  2. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation. 2000;102:1216–1220
  3. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342–1349
  4. Zahid M, Sonel AF, Kelley ME, Wall L, Whittle J, Fine MJ, et al. Effect of both elevated troponin I and peripheral white blood cell count on prognosis in patients with suspected myocardial injury. Am J Cardiol. 2005;95:970–972
  5. Cannon CP, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes (A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)). J Am Coll Cardiol. 2001;38:2114–2130
  6. Katus HA, Remppis A, Neumann FJ, Scheffold T, Diederich KW, Vinar G, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902–912
  7. Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117–2126
  8. Al-Mallah M, Zuberi O, Arida M, Kim HE. Positive troponin in diabetic ketoacidosis without evident acute coronary syndrome predicts adverse cardiac events. Clin Cardiol. 2008;31:67–71
  9. Ausset S, Auroy Y, Lambert E, Vest P, Plotton C, Rigal S, et al. Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome. Eur J Anæsthesiol. 2008;25:158–164
  10. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116:427–433
  11. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med. 2008;36:759–765

PII: S0002-9149(09)00727-9

doi: 10.1016/j.amjcard.2009.03.012

American Journal of Cardiology
Volume 104, Issue 2 , Pages 164-168 , 15 July 2009

Article Tools

* Image Usage & Resolution